Therapeutic plasma exchange reduced circulating microplastics by approximately 60% in patients with elevated baseline levels, achieving statistical significance (p < 0.001). This represents the first clinical evidence that a mechanical intervention can effectively remove microplastic particles from human blood.
Key Points
- Plasma exchange reduced mean microplastics from 52.2 to 21.1 particles per 100µL
- Study included over 100 patients with standardized PlasticTox assay measurement
- First clinical evidence of microplastic removal through medical intervention
Longevity Analysis
Microplastic accumulation represents an emerging toxicological challenge with poorly understood but potentially significant health consequences across lifespan. The demonstration that plasma exchange can mechanically clear these particles from circulation establishes proof of concept for active detoxification strategies. This finding opens investigation into whether chronic microplastic burden contributes to age-related disease progression and whether periodic clearance protocols might mitigate long-term tissue accumulation. The clinical relevance depends on establishing whether circulating microplastic levels associate with measurable health outcomes and whether sustained reduction produces meaningful longevity benefits.
Original published by Longevity.Technology.